Table 2.
Duration of surgery and use of vasopressors and inotropes. †Vasopressor use was expressed by the cumulative number of min in which a patient received phenylephrine, ephedrine, adrenaline, noradrenaline or dopamine i.v. during surgery. ‡Inotrope use was expressed by the cumulative number of min in which a patient received milrinone or dobutamine i.v. during surgery. AUC, area under the curve; MAP, mean arterial pressure; IQR, interquartile range; sd, standard deviation
All patients (n=734) | Non-delirious patients (n=635) | Delirium patients (n=99) | P-values | |
---|---|---|---|---|
Duration of surgery, mean (sd), min | 284 (86) | 282 (83) | 299 (100) | 0.16 |
Duration of cardiopulmonary bypass, mean (sd), min | 91 (53) | 91 (53) | 95 (51) | 0.21 |
Duration of cross-clamp time, mean (sd), min | 31 (25) | 29 (23) | 38 (35) | <0.01 |
Reoperation, n (%), yes | 45 (6) | 35 (5) | 10 (10) | 0.08 |
Baseline bp, mean (sd), mm Hg | 92 (15) | 92 (15) | 90 (17) | 0.07 |
Total min any vasopressor, median (IQR), min | 54 (0–165) | 46 (0–154) | 119 (0–226) | 0.01 |
Total min any inotrope, median (IQR), min | 0 (0–0) | 0 (0–0) | 0 (0–52) | 0.09 |